Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2022 08:00 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Announces Changes to its Board of Directors

IRVINE, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
November 11, 2021 16:05 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Reports Third Quarter 2021 Financial Results

IRVINE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
November 01, 2021 16:05 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences

IRVINE, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
October 14, 2021 08:00 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Announces Notice of Allowance for Patent Application on REN001

IRVINE, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
October 11, 2021 08:00 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer

IRVINE, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies...
September 28, 2021 08:26 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Hosting Key Opinion Leader Webinar on McArdle Disease and other Genetic Mitochondrial Myopathies

IRVINE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
September 09, 2021 09:12 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences

IRVINE, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
August 11, 2021 05:55 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Reports Second Quarter 2021 Financial Results

IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
July 28, 2021 08:00 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study

IRVINE, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies...
July 09, 2021 08:00 ET | Source: Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction

SAN DIEGO, July 09, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right